The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Nuclear factor-κB in cancer development and progression
Abstract
Nuclear factor-kappaB (NF-kappaB) transcription factors and the signalling pathways that activate them are central coordinators of innate and adaptive immune responses. More recently, it has become clear that NF-kappaB signalling also has a critical role in cancer development and progression. NF-kappaB provides a mechanistic link between inflammation and cancer, and is a major factor controlling the ability of both pre-neoplastic and malignant cells to resist apoptosis-based tumour-surveillance mechanisms. NF-kappaB might also regulate tumour angiogenesis and invasiveness, and the signalling pathways that mediate its activation provide attractive targets for new chemopreventive and chemotherapeutic approaches.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“When NF-κB is activated, transcription of proinflammatory immune response genes such as Tnfα and Il1 occurs, which leads to translation and production of proinflammatory cytokines that serve to coordinate the inflammatory response (Karin, 2006).”
From Sleep health: Reciprocal regulation of sleep and innate immunity (2017) · cites this paper as Karin, 2006
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Pathogen Recognition and Innate Immunity
Akira, S., Uematsu, S., & Takeuchi, O. (2006) · Cell · doi:10.1016/j.cell.2006.02.015 · Cited by 12,401
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
Phosphorylation meets ubiquitination: the control of NF-κB activity
Karin, M., & Ben-Neriah, Y. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.621 · Cited by 4,766
Self-citationDanial, N. N., & Korsmeyer, S. J. (2004) · Cell · doi:10.1016/s0092-8674(04)00046-7 · Cited by 4,651
Toll-like receptors and innate immunity
Medzhitov, R. (2001) · Nature Reviews Immunology · doi:10.1038/35100529 · Cited by 4,308
NF-κB regulation in the immune system
Li, Q., & Verma, I. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri910 · Cited by 4,007
Missing Pieces in the NF-κB Puzzle
Ghosh, S., & Karin, M. (2002) · Cell · doi:10.1016/s0092-8674(02)00703-1 · Cited by 3,638
Self-citationNF-κB: linking inflammation and immunity to cancer development and progression
Karin, M., & Greten, F. R. (2005) · Nature reviews. Immunology · doi:10.1038/nri1703 · Cited by 3,175
Self-citation
Cited by
Sorted by citations
Items 901–1,000 of 1,010
The Tumor Stroma as Mediator of Drug Resistance - A Potential Target to Improve Cancer Therapy?
Sebens, S., & Schäfer, H. (2012) · Current Pharmaceutical Biotechnology · doi:10.2174/138920112802501999 · Cited by 70
Alantolactone induces activation of apoptosis in human hepatoma cells
Lei, J., Yu, J. J., Yin, Y., Yan-wen, L., & Zou, G. (2012) · Food and Chemical Toxicology · doi:10.1016/j.fct.2012.06.014 · Cited by 70
Wong, V. K. W., Zhang, M. M., Zhou, H., Lam, K. Y. C., Chan, P. L., Law, C. K. M., Yue, P. Y. K., & Liu, L. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/745295 · Cited by 68
Zeng, Q., Li, S., Zhou, Y., Ou, W., Cai, X., Zhang, L., Huang, W., Huang, L., & Wang, Q. (2013) · Cytokine · doi:10.1016/j.cyto.2013.09.017 · Cited by 69
Tang, S., Xiang, T., Huang, S., Zhou, J., Wang, Z., Xie, R., Long, H., & Zhu, B. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.03.034 · Cited by 69
Molecular targets and anti-cancer potential of escin
Cheong, D. H. J., Arfuso, F., Sethi, G., Wang, L., Hui, K. M., Kumar, A. P., & Tran, T. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.02.027 · Cited by 70
Trinh, D. V., Zhu, N., Farhang, G., Kim, B., & Huxford, T. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.03.060 · Cited by 73
Elevated Pentraxin 3 in bone metastatic breast cancer is correlated with osteolytic function
Choi, B., Lee, E. J., Song, D., Yoon, S. C., Chung, Y., Jang, Y., Kim, S., Song, Y., Kang, S., Yoon, S., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.1664 · Cited by 68
Pancione, M., Forte, N. R., Sabatino, L., Tomaselli, E., Parente, D., Febbraro, A., & Colantuoni, V. (2009) · Human Pathology · doi:10.1016/j.humpath.2008.08.019 · Cited by 68
Chronic Inflammation and Colorectal Cancer: The Role of Vascular Endothelial Growth Factor
Hu, T., Li, L., Shen, J., Zhang, L., & Cho, C. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666150514104244 · Cited by 68
Irwin, M. R. (2022) · Temperature · doi:10.1080/23328940.2022.2109932 · Cited by 80
Hallmarks of Cancer Affected by the MIF Cytokine Family
Barthelmess, R. M., Stijlemans, B., & Ginderachter, J. A. V. (2023) · Cancers · doi:10.3390/cancers15020395 · Cited by 68
Inflammation and Barrett's carcinogenesis
Poehlmann, A., Kuester, D., Malfertheiner, P., Guenther, T., & Roessner, A. (2012) · Pathology - Research and Practice · doi:10.1016/j.prp.2012.03.007 · Cited by 68
Martı́n, D., Galisteo, R., Ji, Y., Montaner, S., & Gutkind, J. S. (2007) · Oncogene · doi:10.1038/sj.onc.1210817 · Cited by 68
Targeting multiple signal pathways by chemopreventive agents for cancer prevention and therapy
Sarkar, F. H., & Li, Y.-W. (2007) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2007.00689.x · Cited by 68
Choi, E. S., Kim, H., & Han, I. (2013) · Annals of Surgical Oncology · doi:10.1245/s10434-013-3418-3 · Cited by 66
Inagaki, M., Omori, E., Kim, J.-Y., Komatsu, Y., Scott, G., Ray, M. K., Yamada, G., Matsumoto, K., Mishina, Y., & Ninomiya-Tsuji, J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m807574200 · Cited by 68
Xenobiotic receptor meets NF-κB, a collision in the small bowel
Xie, W., & Tian, Y. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.08.004 · Cited by 68
Degree of roasting is the main determinant of the effects of coffee on NF-κB and EpRE
Paur, I., Balstad, T. R., & Blomhoff, R. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.02.005 · Cited by 68
MicroRNA-130a can inhibit hepatitis B virus replication via targeting PGC1α and PPARγ
Huang, J., Chou, S.-F., Lee, J.-W., Chen, H.-L., Chen, C., Tao, M., & Shih, C. (2015) · RNA · doi:10.1261/rna.048744.114 · Cited by 69
Deng, J., Zhao, L., Yuan, X., Li, Y., Shi, J., Zhang, H., Zhao, Y., Han, L., Wang, H., Yan, Y., et al. (2022) · Nutrients · doi:10.3390/nu14040726 · Cited by 67
Fermoselle, C., García‐Arumí, E., Puig‐Vilanova, E., Andreu, A. L., Urtreger, A. J., Joffé, E. B. D. K., Tejedor, A., Puente‐Maestu, L., & Barreiro, E. (2013) · Experimental Physiology · doi:10.1113/expphysiol.2013.072496 · Cited by 67
Wang, J., Hou, J., Zhang, P., Li, D., Zhang, C., & Liu, J. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0852-8 · Cited by 67
Cancer, Inflammation, and Insights from Ayurveda
Sumantran, V. N., & Tillu, G. S. (2012) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2012/306346 · Cited by 70
High‐fat diet increases NF‐κB signaling in the prostate of reporter mice
Vykhovanets, E. V., Shankar, E., Vykhovanets, O. V., Shukla, S., & Gupta, S. (2010) · The Prostate · doi:10.1002/pros.21230 · Cited by 67
Pimecrolimus Enhances TLR2/6-Induced Expression of Antimicrobial Peptides in Keratinocytes
Büchau, A. S., Schauber, J., Hultsch, T., Stuetz, A., & Gallo, R. L. (2008) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.135 · Cited by 69
Toad Glandular Secretions and Skin Extractions as Anti‐Inflammatory and Anticancer Agents
Qi, J., Tan, C. K., Hashimi, S. M., Zulfiker, A. H. M., Good, D. M., & Wei, M. Q. (2014) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2014/312684 · Cited by 67
Fish consumption and risk of gastrointestinal cancers: A meta-analysis of cohort studies
Yu, X. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i41.15398 · Cited by 68
Xu, T., Shen, H., Liu, L., & Shu, Y. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.4.2325 · Cited by 67
Grill, A. E., Koniar, B. L., & Panyam, J. (2014) · Drug Delivery and Translational Research · doi:10.1007/s13346-014-0199-6 · Cited by 67
Palgrave, C. J., Gilmour, L., Lowden, C. S., Lillico, S. G., Mellencamp, M. A., & Whitelaw, B. (2011) · Journal of Virology · doi:10.1128/jvi.00331-11 · Cited by 67
NF-κB signaling as a driver of ageing
Osorio, F. G., Soria‐Valles, C., Santiago‐Fernández, O., Freije, J. M. P., & López-Otı́n, C. (2016) · International review of cytology · doi:10.1016/bs.ircmb.2016.04.003 · Cited by 67
Tumor-Associated Macrophages Induce Endocrine Therapy Resistance in ER+ Breast Cancer Cells
Castellaro, A. M., Rodríguez-Baili, M. C., Tada, C. D., & Gil, G. A. (2019) · Cancers · doi:10.3390/cancers11020189 · Cited by 68
Liu, J., & Lin, A. (2007) · Oncogene · doi:10.1038/sj.onc.1210417 · Cited by 67
Alhaddad, H., Kim, N. T., Aal-Aaboda, M. S., Althobaiti, Y. S., Leighton, J. L., Boddu, S. H. S., Wei, Y., & Sari, Y. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00366 · Cited by 66
Remodeling the blood–brain barrier microenvironment by natural products for brain tumor therapy
Zhao, X. G., Chen, R., Liu, M., Feng, J., Chen, J., & Hu, K. (2017) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2017.07.002 · Cited by 66
Guo, Y., Zang, Y., Lv, L., Cai, F., Qian, T., Zhang, G., & Feng, Q. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7747 · Cited by 67
Khan, Z. A., Labala, R. K., Yumnamcha, T., Devi, S. D., Mondal, G., Devi, H. S., Rajiv, C., Bharali, R., & Chattoraj, A. (2018) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2018.02.101 · Cited by 66
Cataldi, M. P., Shah, N. R., Felt, S. A., & Grdzelishvili, V. Z. (2015) · Virology · doi:10.1016/j.virol.2015.08.003 · Cited by 66
Angiogenesis in pre-malignant conditions
Menakuru, S. R., Brown, N. J., Staton, C. A., & Reed, M. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604733 · Cited by 67
Activated p53 induces NF-κB DNA binding but suppresses its transcriptional activation
Kawauchi, K., Araki, K., Tobiume, K., & Tanaka, N. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.05.021 · Cited by 66
TRAF2 is an NF-κB-activating oncogene in epithelial cancers
Shen, R. R., Zhou, A. Y., Kim, E., O’Connell, J. T., Hägerstrand, D., Beroukhim, R., & Hahn, W. C. (2013) · Oncogene · doi:10.1038/onc.2013.543 · Cited by 70
Hamed, E. A., Zakhary, M. M., & Maximous, D. (2012) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-012-1176-4 · Cited by 66
FAT10 mediates the effect of TNF-α in inducing chromosomal instability
Ren, J., Wang, Y., Gao, Y., Mehta, S. B., & Lee, C. G. L. (2011) · Journal of Cell Science · doi:10.1242/jcs.087403 · Cited by 66
Cancer-specific MALDI-TOF profiles of blood serum and plasma: Biological meaning and perspectives
Karpova, M. A., Moshkovskii, S. A., Toropygin, I. Y., & Archakov, A. I. (2009) · Journal of Proteomics · doi:10.1016/j.jprot.2009.09.011 · Cited by 66
Xie, W., Huang, Y., Xie, W., Guo, A., & Wu, W. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010850 · Cited by 67
Pringle, L. M., Young, R., Quick, L. A., Riquelme, D. N., Oliveira, A. M., May, M. J., & Chou, M. M. (2011) · Oncogene · doi:10.1038/onc.2011.520 · Cited by 66
Suh, N., Reddy, B. S., DeCastro, A., Paul, S., Lee, H. J., Smolarek, A. K., So, J. Y., Simi, B., Wang, C. X., Janakiram, N. B., et al. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0222 · Cited by 66
Diverse mechanisms for activation of Wnt signalling in the ovarian tumour microenvironment
Barbolina, M. V., Burkhalter, R. J., & Stack, M. S. (2011) · Biochemical Journal · doi:10.1042/bj20110112 · Cited by 66
Ishikawa, K., Yagi-Nakanishi, S., Nakanishi, Y., Kondo, S., Tsuji, A., Endo, K., Wakisaka, N., Murono, S., & Yoshizaki, T. (2014) · Auris Nasus Larynx · doi:10.1016/j.anl.2014.08.007 · Cited by 66
The role and mechanism of β‑arrestins in cancer invasion and metastasis (Review)
Song, Q., Ji, Q., & Li, Q. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.3288 · Cited by 73
Bianchi, G., Ravera, S., Traverso, C., Amaro, A. A., Piaggio, F., Emionite, L., Bachetti, T., Pfeffer, U., & Raffaghello, L. (2018) · Carcinogenesis · doi:10.1093/carcin/bgy076 · Cited by 67
Combined deletion of cathepsin protease family members reveals compensatory mechanisms in cancerPreprint
Akkari, L., Gocheva, V., Quick, M. L., Kester, J. C., Spencer, A. K., Garfall, A. L., Bowman, R. L., & Joyce, J. A. (2016) · Genes & Development · doi:10.1101/gad.270439.115 · Cited by 66
Yu, B., Mao, Y., Bai, L., Herman, S. E. M., Wang, X., Ramanunni, A., Jin, Y., Mo, X. M., Cheney, C. M., Chan, K. K., et al. (2012) · Blood · doi:10.1182/blood-2012-01-407742 · Cited by 67
MicroRNA-Based Diagnosis and Treatment of Metastatic Human Osteosarcoma
Sasaki, R., Osaki, M., & Okada, F. (2019) · Cancers · doi:10.3390/cancers11040553 · Cited by 66
Aging, cancer, and antitumor immunity
Ikeda, H., & Togashi, Y. (2021) · International Journal of Clinical Oncology · doi:10.1007/s10147-021-01913-z · Cited by 65
Gray, M., Marland, J. R. K., Murray, A. F., Argyle, D. J., & Potter, M. A. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11060471 · Cited by 65
Infante, M. V., Allavena, P., Garlanda, C., Nebuloni, M., Morenghi, E., Rahal, D., Roncalli, M. G., Cavuto, S., Pesce, S., Monari, M., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29822 · Cited by 65
Ding, L.-H., Xie, Y., Park, S., Xiao, G., & Story, M. D. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn234 · Cited by 66
Beauchef, G., Bigot, N., Kypriotou, M., Renard, E., Porée, B., Widom, R. L., Dompmartin, A., Oddos, T., Maquart, F., Demoor, M., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.286443 · Cited by 65
Zhang, Y., Shi, S., Zhao, M., Chai, X., & Tu, P. (2013) · Fitoterapia · doi:10.1016/j.fitote.2013.03.024 · Cited by 65
Tran, K. Q., Tin, A. S., & Firestone, G. L. (2013) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000054 · Cited by 65
Sourbier, C., Danilin, S., Lindner, V., Steger, J., Rothhut, S., Meyer, N., Didier Jacqmin, D., Helwig, J., Lang, H., & Massfelder, T. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0632 · Cited by 64
Nabekura, T., Hiroi, T., Kawasaki, T., & Uwai, Y. (2015) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2015.01.007 · Cited by 65
Dietary fat’gene interactions in cancer
Chen, Y. Q., Edwards, I. J., Kridel, S. J., Thornburg, T., & Berquin, I. M. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9075-x · Cited by 66
Ovarian cancer molecular pathology
Longuespée, R., Boyon, C., Desmons, A., Vinatier, D., Leblanc, É., Farré, I., Wisztorski, M., Ly, K., D’Anjou, F., Day, R. W., et al. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-012-9383-7 · Cited by 64
Santacatterina, F., Sánchez-Cenizo, L., Formentini, L., Mobasher, M. A., Casas, E., Rueda, C. B., Martínez‐Reyes, I., de Arenas, C. N., García‐Bermúdez, J., Zapata, J. M., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6357 · Cited by 68
Martins, G. R., Gelaleti, G. B., Moschetta, M. G., MASCHIO, L. B., & Zuccari, D. A. P. D. C. (2016) · Mediators of Inflammation · doi:10.1155/2016/9512743 · Cited by 65
Lin, L., Chen, S., Wang, H., Gao, B., Kallakury, B., Bhuvaneshwar, K., Cahn, K., Gusev, Y., Wang, X., Wu, Y., et al. (2021) · Theranostics · doi:10.7150/thno.49819 · Cited by 64
Rosato, R. R., Kolla, S. S., Hock, S. K., Almenara, J. A., Patel, A. K., Amin, S., Atadja, P. W., Fisher, P. B., Dent, P., & Grant, S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.095208 · Cited by 64
RetractedBiology and Clinical Relevance of Acute Myeloid Leukemia Stem Cells
Reinisch, A., Chan, S. M., Thomas, D., & Majeti, R. (2015) · Seminars in Hematology · doi:10.1053/j.seminhematol.2015.03.008 · Cited by 68
Pouyet, L., Roisin-Bouffay, C., Clément, A., Millet, V., Garcia, S., Chasson, L., Issaly, N., Rostan, A., Hofman, P. M., Naquet, P., et al. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21031 · Cited by 64
Wang, R., Dashwood, W., Nian, H., Löhr, C. V., Fischer, K. A., Tsuchiya, N., Nakagama, H., Ashktorab, H., & Dashwood, R. H. (2010) · International Journal of Cancer · doi:10.1002/ijc.25610 · Cited by 66
Toll-like receptors as therapeutic targets in gastrointestinal diseases
Pimentel‐Nunes, P., Soares, J., Roncon‐Albuquerque, R., Dinis-Ribeiro, M. J., & Leite-Moreira, A. F. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728221003642027 · Cited by 70
Liao, K. L., Xia, B., Zhuang, Q.-Y., Hou, M., Zhang, Y., Luo, B., Qiu, Y., Gao, Y., Li, X., Chen, H., et al. (2015) · Theranostics · doi:10.7150/thno.8387 · Cited by 65
He, Y., Zhang, H., Yin, J., Xie, J., Tan, X., Liu, S., Zhang, Q., Li, C., Zhao, J., Wang, H., et al. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp226 · Cited by 64
Izzo, J. G., Correa, A. M., Wu, T., Malhotra, U., Chao, C., Luthra, R., Ensor, J., Dekovich, A. A., Liao, Z. X., Hittelman, W. N., et al. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0351 · Cited by 64
Gu, X., Gao, X., Cui, M., Xie, M., Peng, C., Bai, Y., Guo, W., Han, L., Gu, X., & Xiong, W. (2016) · Oncotarget · doi:10.18632/oncotarget.10490 · Cited by 63
Trametes robiniophila Murr: a traditional Chinese medicine with potent anti-tumor effects
Pan, J., Yang, C., Zhou, J., & Huang, J. (2019) · Cancer Management and Research · doi:10.2147/cmar.s193174 · Cited by 63
Naples Prognostic Score Is a Useful Prognostic Marker in Patients With Metastatic Colorectal Cancer
Miyamoto, Y., Hiyoshi, Y., Daitoku, N., Okadome, K., Sakamoto, Y., Yamashita, K., Kuroda, D., Sawayama, H., Iwatsuki, M., Baba, Y., et al. (2019) · Diseases of the Colon & Rectum · doi:10.1097/dcr.0000000000001484 · Cited by 62
Menegazzi, M., Masiello, P., & Novelli, M. (2020) · Antioxidants · doi:10.3390/antiox10010018 · Cited by 69
Yang, T., Deng, Z., Xu, L., Li, X., Tan, Y., Qian, Y., Lü, Y., Tian, L., Yao, W., & Wang, J. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02235-8 · Cited by 62
Phenethyl isothiocyanate sensitizes human cervical cancer cells to apoptosis induced by cisplatin
Wang, X., Govind, S., Sajankila, S. P., Mi, L., Roy, R., & Chung, F. (2011) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201000560 · Cited by 63
Inflammation and gastrointestinal cancer: An overview
Marusawa, H., & Jenkins, B. J. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.08.025 · Cited by 63
Qiao, L., Zhao, T., Wang, F.-Z., Shan, C., Ye, L., & Zhang, X. (2008) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2008.00751.x · Cited by 63
Wu, B., Yao, H., Wang, S., & Xu, R. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.03.063 · Cited by 64
Zhou, B., Zuo, Y., Li, B., Wang, H., Liu, H., Wang, X., Qiu, X., Hu, Y., Wen, S., Du, J., et al. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-1057 · Cited by 63
Enhanced frequency and potential mechanism of B regulatory cells in patients with lung cancer
Zhou, J.-B., Min, Z., Zhang, D., Wang, W., Marincola, F., & Wang, X.-D. (2014) · Journal of Translational Medicine · doi:10.1186/s12967-014-0304-0 · Cited by 59
Cho, S., Li, D., Stafford, L. J., Luo, J., Rodriguez‐Villanueva, M., Wang, Y., & Liu, M. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22216 · Cited by 63
Splicing variant of AIMP2 as an effective target against chemoresistant ovarian cancer
Choi, J. W., Lee, J., Kim, J. K., Jeon, H.-K., Choi, J., Kim, D. G., Kim, B., Nam, D., Kim, H. J., Yun, S. H., et al. (2012) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjs018 · Cited by 63
Song, J., Feng, L., Zhong, R., Xia, Z., Zhang, L. R., Cui, L., Yan, H., Jia, X., & Zhang, Z. (2016) · Molecular Carcinogenesis · doi:10.1002/mc.22471 · Cited by 64
Li, M., Zhang, M., Zhang, Z.-L., Liu, N., Han, X., Liu, Q., Deng, W., & Liao, C.-X. (2017) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504016x14742891049073 · Cited by 64
Xu, J., Shen, W., Pei, B., Wang, X., Sun, D., Li, Y., Xiu, L., Liu, X., Lu, Y. F., Zhang, X., et al. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.09.012 · Cited by 65
Wang, D., Zhang, M., Wang, T., Cai, M., Qian, F., Sun, Y., & Wang, Y. (2019) · Food & Function · doi:10.1039/c9fo00572b · Cited by 64
Blaylock, R. L. (2015) · Surgical Neurology International · doi:10.4103/2152-7806.157890 · Cited by 66
TWIST and ovarian cancer stem cells: implications for chemoresistance and metastasis
Nuti, S. V., Mor, G., Li, P., & Yin, G. (2014) · Oncotarget · doi:10.18632/oncotarget.2428 · Cited by 64
The identification of molecular target of (20S) ginsenoside Rh2 for its anti-cancer activity
Wang, Y., Lin, Y., Li, H., Li, Y., Song, Z., & Jin, Y.-H. (2017) · Scientific Reports · doi:10.1038/s41598-017-12572-4 · Cited by 62
Lu, C.-S., Lin, C., Chang, Y.-H., Chen, H., Chung, W.-C., Lai, W., Ho, C., Wang, T., Chen, C., Yeh, C.-L., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001392 · Cited by 66
MSC and Tumors: Homing, Differentiation, and Secretion Influence Therapeutic Potential
D’souza, N., Burns, J. S., Grisendi, G., Candini, O., Veronesi, E., Piccinno, M. S., Horwitz, E. M., Paolucci, P., Conte, P., & Dominici, M. (2012) · Advances in biochemical engineering, biotechnology · doi:10.1007/10_2012_150 · Cited by 63
Soy isoflavones sensitize cancer cells to radiotherapy
Hillman, G. G., & Singh‐Gupta, V. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.04.039 · Cited by 62
Metadata
- Authors
- Karin, M.
- Affiliations
- University of California San Diego (US)
- Corresponding author
- Karin, Michael
- ORCID
- Karin, Michael
- Venue
- Nature
- Published
- 2006-05
- Volume
- 441
- Issue
- 7092
- Pages
- 431-436
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2315613727
- Cited by
- 3,519
- References
- 71
- Citations by year
- 2026: 60 · 2025: 97 · 2024: 111 · 2023: 118 · 2022: 118 · 2021: 159 · 2020: 162 · 2019: 133 · 2018: 168 · 2017: 149 · 2016: 192 · 2015: 235 · 2014: 203 · 2013: 231 · 2012: 250
- FWCI
- 15.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Health Sciences › Medicine › Complementary and alternative medicine › Natural Compounds in Disease Treatment
- Keywords
- NF-κB, carcinogenesis, tumor progression, inflammation and cancer, apoptosis resistance, tumor surveillance, tumor angiogenesis, tumour invasiveness, chemoprevention, chemotherapeutic target, NF-κB signaling
- MeSH terms
- Animals, Humans, Inflammation, Liver Neoplasms, Neoplasms, Skin Neoplasms, NF-kappa B, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review